SCHEMBL3369703

SCHEMBL3369703

O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 1.00
▸ ACLY P53396 2/20 0.37
▸ LMNA P02545 1/20 0.36
▸ CA2 P00918 11/20 0.36
▸ CA1 P00915 10/20 0.36
▸ MMP1 P03956 2/20 0.36
▸ MMP2 P08253 2/20 0.36
▸ MMP9 P14780 2/20 0.36
▸ MMP8 P22894 2/20 0.36
▸ MMP13 P45452 2/20 0.36
▸ GAA P10253 1/20 0.33
▸ F2 P00734 1/20 0.32
▸ PRSS1 P07477 1/20 0.32
▸ PRSS2 P07478 1/20 0.32
▸ PRSS3 P35030 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HDAC3 O15379 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82682 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL3368187 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL3368109 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL3370867 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL22556 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL25223581 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL517311 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL64484 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL20657170 1.00 THRB (1.00) THRBACLYLMNACA2CA1
SCHEMBL337248 1.00 THRB (1.00) THRBACLYLMNACA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119881158-A Method for rapidly screening and targeting quantitative PFAS in water body and application thereof 湖州市疾病预防控制中心 2025-04-25 — — CN claimed
WO-2025061960-A1 PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS CHIRON AS (NO) 2025-03-27 — — WO claimed
EP-4527829-A1 PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS Chiron AS (NO) 2025-03-26 — — EP claimed
WO-2025049798-A1 SYSTEMS, METHODS, AND DEVICES FOR DESTRUCTION OF PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND FOR REACTIVATING SPENT ACTIVATED CARBON 6K INC. (US) 2025-03-06 — — WO claimed
CN-115068977-B Preparation method and application of solid-phase microextraction probe for highly selectively enriching perfluorinated compounds 广东省科学院测试分析研究所(中国广州分析测试中心) 2023-09-08 — — CN claimed
CN-115068977-A Preparation method and application of solid-phase microextraction probe for high-selectivity enrichment of perfluorinated compounds 广东省科学院测试分析研究所(中国广州分析测试中心) 2022-09-20 — — CN claimed
CN-119881158-A Method for rapidly screening and targeting quantitative PFAS in water body and application thereof 湖州市疾病预防控制中心 2025-04-25 — — CN disclosed
WO-2025061960-A1 PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS CHIRON AS (NO) 2025-03-27 — — WO disclosed
EP-4527829-A1 PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS Chiron AS (NO) 2025-03-26 — — EP disclosed
WO-2025049798-A1 SYSTEMS, METHODS, AND DEVICES FOR DESTRUCTION OF PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND FOR REACTIVATING SPENT ACTIVATED CARBON 6K INC. (US) 2025-03-06 — — WO disclosed
US-11978576-B2 Method for preparing sintered magnet and sintered magnet LG CHEM, LTD. (KR) 2024-05-07 — — US disclosed
CN-115068977-B Preparation method and application of solid-phase microextraction probe for highly selectively enriching perfluorinated compounds 广东省科学院测试分析研究所(中国广州分析测试中心) 2023-09-08 — — CN disclosed
EP-3754676-B1 METHOD FOR MANUFACTURING SINTERED MAGNET LG CHEMICAL LTD (KR) 2023-07-12 — — EP disclosed
US-7318991-B2 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-15 — — US disclosed
US-7101918-B2 Hybrid type onium salt WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2006-09-05 — — US disclosed
EP-1690685-A2 Planographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 2006-08-16 — — EP disclosed
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) 2005-10-20 — — US disclosed
US-20050020710-A1 Hybrid onium salt WAKO PURE CHEMICALS INDUSTRIES, LTD. (JP) 2005-01-27 — — US disclosed
EP-1481973-A1 HETEROCYCLE-BEARING ONIUM SALTS Wako Pure Chemical Industries, Ltd. (JP) 2004-12-01 — — EP disclosed
EP-1443042-A1 HYBRID ONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether NOX4, CBR1, CBR3 THRB 2315/4885ACLY 3862/4885LMNA 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback